Menú
banner-risc-cardiovascular

Publicacions

Safety monitoring of COVID-19 vaccines in multiple European countries: Initial results from the COVID-19 vaccine monitor (CVM)

M. RAETHKE, N. LUXI, G. TRIFIRÒ, N. THURIN, D. MENTZER, E. DE CLERCQ, B. KOVACIC, K. MORTON, F. MARQUES, S. SONDERLICHOVÁ, F. VILLALOBOS, F. RIEFOLO, F. VAN HUNSEL and M. STURKENBOOM
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2023 Oct 1;

Veure més:
Myocarditis associated with SARS-CoV-2 vaccines by dose and brand in three European countries using large electronic health care data sources: A self-controlled risk interval study in the COVID-19 vaccine monitor study

C. DURÁN, S. BELITSER, S. BOTS, F. RIEFOLO, D. MESSINA, R. GINI, P. GARCÍA-POZA, M. PÉREZ, J. CARRERAS, E. CORRECHER-MARTÍNEZ, A. URCHUEGUÍA, P. SOUVEREIN, F. VILLALOBOS, J. RIERA-ARNAU, A. SCHULTZE, I. DOUGLAS, O. KLUNGEL and M. STURKENBOOM
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2023 Oct 1;

Veure més:
Effect of Lipids on Diabetic Retinopathy in a Large Cohort of Diabetic Patients after 10 Years of Follow-Up

P. ROMERO-AROCA, R. VERGES, J. PASCUAL-FONTANILLES, A. VALLS, J. FRANCH, J. BARROT, X. MUNDET, A. LA TORRE, A. MORENO, R. SAGARRA, J. BASORA, E. GARCIA-CURTO and M. BAGET-BERNALDIZ
Journal of Clinical Medicine. 2023 Oct 1; . doi:10.3390/jcm12206674; PMID:37892811

Veure més:
VAC4EU study tracking post-authorization safety of mRNA-1273 in five European countries: How to overcome the methodological challenges

W. AARTS, J. CHOI, D. ROY, C. FRY, S. LANE, R. GINI, A. GIRARDI, O. PAOLETTI, F. VILLALOBOS, C. BISSACCO, E. SEGUNDO, A. LUPATTELLI, J. ZHAO, D. WEIBEL, D. ESPOSITO, D. MARTIN, S. ST LAURENT, M. EMILEBACKER, V. EHRENSTEIN, S. SORUP and B. GOODALE
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2023 Oct 1;

Veure més:
Using negative control outcomes to identify unmeasured confounding in a self-controlled risk interval study evaluating the COVID-19 vaccine myocarditis safety signal

S. BOTS, S. BELITSER, C. DURÁN, J. RIERA-ARNAU, A. SCHULTZE, D. MESSINA, E. SEGUNDO, I. DOUGLAS, J. CARRERAS, P. GARCÍA-POZA, R. GINI, C. HUERTA, M. MARTÍN-PEREZ, I. MARTIN, O. PAOLETTI, C. BISSACCO, E. CORRECHER-MARTÍNEZ, P. SOUVEREIN, A. URCHUEGUIA, F. VILLALOBOS, M. STURKENBOOM and O. KLUNGEL
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2023 Oct 1;

Veure més:
Incidence of COVID-19 disease severity in a cohort of 4.4 million Italian and Spanish children from six healthcare databases

C. DURÁN, F. RIEFOLO, R. GINI, D. MESSINA, P. GARCÍA-POZA, M. MARTÍN-PEREZ, F. VILLALOBOS, M. PALLEJÀ-MILLÁN, E. BARBIERI, L. STONA, Y. INGRASCIOTTA, J. CARRERAS, E. CORRECHER-MARTÍNEZ, A. URCHUEGUÍA, M. TARI, V. IENTILE and M. STURKENBOOM
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2023 Oct 1;

Veure més:
Importance of Maternal Iron Status on the Improvement of Cognitive Function in Children After Prenatal Iron Supplementation.

Iglesias-Vázquez L, Voltas N, Hernández-Martínez C, Canals J, Coronel P, Gimeno M, Basora J and Arija V
AMERICAN JOURNAL OF PREVENTIVE MEDICINE. 2023 Sep 1; . doi:10.1016/j.amepre.2023.02.006; PMID:36906495

Veure més:
Adjusting prenatal iron supplementation to women’s needs in early pregnancy to improve maternal iron status in late pregnancy

L. IGLESIAS-VÁZQUEZ, N. ARANDA, E. APARICIO, J. BASORA and V. ARIJA
ANNALS OF NUTRITION AND METABOLISM. 2023 Aug 1;

Veure més:
Injury-induced activation of the endocannabinoid system promotes axon regeneration

S. MARTINEZ-TORRES, F. MESQUIDA-VENY, J. DEL RIO and A. HERVERA
iScience. 2023 Jun 16; . doi:10.1016/j.isci.2023.106814; PMID:37235048

Veure més:
Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials.

Ahmadizar F, Luxi N, Raethke M, Schmikli S, Riefolo F, Saraswati PW, Bucsa C, Osman A, Liddiard M, Maques FB, Petrelli G, Sonderlichová S, Thurin NH, Villalobos F, Trifirò G and Sturkenboom M
DRUG SAFETY. 2023 Jun 1; . doi:10.1007/s40264-023-01304-5; PMID:37103643

Veure més:

Patronat

Col·laboradors

Acreditacions